Related Experiment Videos
Prostaglandins and cyclic-AMP in human semen
Prostaglandins, Leukotrienes, and Medicine
|January 1, 1982
Summary
Semen analysis reveals that cyclic adenosine monophosphate (cAMP) is crucial for sperm motility. Clomiphene citrate treatment increased cAMP levels, suggesting a potential therapeutic pathway for male infertility.
Area of Science:
- Reproductive Biology
- Biochemistry
- Andrology
Background:
- Prostaglandins and cyclic AMP (adenosine monophosphate) are vital signaling molecules in reproductive physiology.
- Alterations in seminal fluid composition are associated with male infertility, including conditions like oligospermia and azoospermia.
Purpose of the Study:
- To investigate the concentrations of prostaglandins E (PGEs) and cyclic AMP in normospermic, oligospermic, and azoospermic human semen.
- To explore the relationship between cyclic AMP, PGEs, and sperm motility.
- To evaluate the effect of clomiphene citrate treatment on seminal cyclic AMP levels.
Main Methods:
- Analysis of prostaglandins E (total PGEs) and cyclic AMP in human semen samples under a nitrogen atmosphere.
- Statistical analysis to determine correlations between cyclic AMP, PGEs, and sperm motility.
- Measurement of seminal cyclic AMP levels before and after a two-month treatment with clomiphene citrate.
Main Results:
- Normospermic semen exhibited higher total PGE levels compared to oligospermic and azoospermic samples.
- While average cyclic AMP levels did not significantly differ across groups, very low levels were predominantly found in oligospermic and azoospermic semen.
- A positive correlation was observed between cyclic AMP and sperm motility (r=+0.56, p<0.0005).
- Clomiphene citrate treatment led to a significant increase in seminal cyclic AMP.
Conclusions:
- Cyclic AMP plays a significant role in regulating human sperm motility.
- The therapeutic effects of clomiphene citrate on human semen may be mediated through an increase in cyclic AMP levels.
- Further research into cAMP modulation could offer new strategies for managing male infertility.